Ticker: RLMD

Company: RELMADA THERAPEUTICS, INC.

Person: SERGIO TRAVERSA, director, officer

Transaction date: Dec. 12, 2025

Reporting date: Dec. 16, 2025

Average share price: 4.12

Bought 27500.0 shares for 113300.0